The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease ; volume:21 ; number:1 ; day:30 ; month:11 ; year:2021 ; pages:1-9 ; date:12.2021
BMC endocrine disorders ; 21, Heft 1 (30.11.2021), 1-9, 12.2021
- Urheber
-
Fang, Ya
Du, Wen-Hua
Zhang, Cao-Xu
Zhao, Shuang-Xia
Song, Huai-Dong
Gao, Guan-Qi
Dong, Mei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-021-00905-4
- URN
-
urn:nbn:de:101:1-2022020506275904459481
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fang, Ya
- Du, Wen-Hua
- Zhang, Cao-Xu
- Zhao, Shuang-Xia
- Song, Huai-Dong
- Gao, Guan-Qi
- Dong, Mei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
The influence of thionamides on intra-thyroidal uptake of 131I during radioiodine-131 treatment of Graves’ disease
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Should radioiodine now be first line treatment for Graves’ disease?
Efficacy of radioiodine in the treatment of primary hyperthyroidism
Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
Trabe Rößlein, trabe
A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
The influence of thionamides on intra-thyroidal uptake of 131I during radioiodine-131 treatment of Graves’ disease
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Should radioiodine now be first line treatment for Graves’ disease?
Efficacy of radioiodine in the treatment of primary hyperthyroidism
Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
Trabe Rößlein, trabe
A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of 131I during radioiodine therapy of Graves’ disease
A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
The influence of thionamides on intra-thyroidal uptake of 131I during radioiodine-131 treatment of Graves’ disease
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Should radioiodine now be first line treatment for Graves’ disease?
Efficacy of radioiodine in the treatment of primary hyperthyroidism
Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves’ disease: role of TRAbs
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
Trabe Rößlein, trabe